These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

161 related items for PubMed ID: 24955483

  • 21. Plasminogen activator inhibitor 1 (PAI-1) levels and gene promoter polymorphisms in subjects with colorectal cancer.
    Smolarz B, Blasiak J, Kulig A, Romanowicz-Makowska H, Dziki A, Ulanska J, Pander B, Szewczyk T.
    J Exp Clin Cancer Res; 2001 Jun; 20(2):247-52. PubMed ID: 11484982
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Impact of the 4G/5G polymorphism in the plasminogen activator inhibitor-1 gene on primary nephrotic syndrome.
    Luo Y, Wang C, Tu H.
    Mol Med Rep; 2014 Mar; 9(3):894-8. PubMed ID: 24435552
    [Abstract] [Full Text] [Related]

  • 24. Investigation of Plasminogen Activator Inhibitor-1 (PAI-1) 4G/5G promoter polymorphism in Indian venous thrombosis patients: A case-control study.
    Prabhudesai A, Shetty S, Ghosh K, Kulkarni B.
    Eur J Haematol; 2017 Sep; 99(3):249-254. PubMed ID: 28561456
    [Abstract] [Full Text] [Related]

  • 25. The Association of Plasminogen Activator Inhibitor Type 1 (PAI-1) Level and PAI-1 4G/5G Gene Polymorphism with the Formation and the Grade of Endometrial Cancer.
    Yıldırım ME, Karakuş S, Kurtulgan HK, Kılıçgün H, Erşan S, Bakır S.
    Biochem Genet; 2017 Aug; 55(4):314-321. PubMed ID: 28303356
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. The prevalence of 4G5G polymorphism of plasminogen activator inhibitor-1 (PAI-1) gene in polycystic ovarian syndrome and its association with plasma PAI-1 levels.
    Diamanti-Kandarakis E, Palioniko G, Alexandraki K, Bergiele A, Koutsouba T, Bartzis M.
    Eur J Endocrinol; 2004 Jun; 150(6):793-8. PubMed ID: 15191349
    [Abstract] [Full Text] [Related]

  • 28. Genetic polymorphism of the plasminogen activator inhibitor-1 is associated with an increased risk of endometrial cancer.
    Su CK, Yeh KT, Yeh CB, Wang PH, Ho ES, Chou MC, Liu KC, Yang SF, Yi YC.
    J Surg Oncol; 2011 Dec; 104(7):755-9. PubMed ID: 21761413
    [Abstract] [Full Text] [Related]

  • 29. Plasminogen activator inhibitor -1 gene 4G/5G polymorphism in patients with breast cancer.
    Eroglu A, Ulu A, Cam R, Akar N.
    J BUON; 2006 Dec; 11(4):481-4. PubMed ID: 17309181
    [Abstract] [Full Text] [Related]

  • 30. 4G/5G polymorphism of PAI-1 gene promoter and fibrinolytic capacity in patients with deep vein thrombosis.
    Sartori MT, Wiman B, Vettore S, Dazzi F, Girolami A, Patrassi GM.
    Thromb Haemost; 1998 Dec; 80(6):956-60. PubMed ID: 9869167
    [Abstract] [Full Text] [Related]

  • 31. The -675 4G/5G PAI-1 polymorphism confers genetic susceptibility to systemic lupus erythematosus, its clinical manifestations, and comorbidities in Mexican-Mestizo population.
    Anaya-Macias BU, De la Cruz-Mosso U, Palafox-Sánchez CA, Parra-Rojas I, Martínez-Bonilla G, González-López L, Gámez-Nava JI, Pérez-Guerrero EE, Barrientos-Avalos SL, Muñoz-Valle JF.
    Autoimmunity; 2020 Mar; 53(2):71-77. PubMed ID: 31829037
    [Abstract] [Full Text] [Related]

  • 32. Relationship of plasminogen activator inhibitor 1 gene 4G/5G polymorphisms to hypertension in Korean women.
    Kim KN, Kim KM, Kim BT, Joo NS, Cho DY, Lee DJ.
    Chin Med J (Engl); 2012 Apr; 125(7):1249-53. PubMed ID: 22613596
    [Abstract] [Full Text] [Related]

  • 33. Plasminogen activator inhibitor type-1 (PAI-1) polymorphism 4G/5G is associated with prostate cancer among men with a positive family history.
    Jorgenson E, Deitcher SR, Cicek M, Liu X, Plummer S, Casey G, Witte JS.
    Prostate; 2007 Feb 01; 67(2):172-7. PubMed ID: 17044080
    [Abstract] [Full Text] [Related]

  • 34. [Plasminogen activator inhibitor type 1 gene polymorphism and thromboses in patients with antiphospholipid syndrome].
    Reshetniak TM, Ostriakova EV, Patrusheva NL, Patrushev LI, Aleksandrova EN, Seredavkina NV, Volkov AV, Nasonov EL.
    Ter Arkh; 2013 Feb 01; 85(1):76-84. PubMed ID: 23536951
    [Abstract] [Full Text] [Related]

  • 35. Role of functional plasminogen-activator-inhibitor-1 4G/5G promoter polymorphism in susceptibility, severity, and outcome of meningococcal disease in Caucasian children.
    Haralambous E, Hibberd ML, Hermans PW, Ninis N, Nadel S, Levin M.
    Crit Care Med; 2003 Dec 01; 31(12):2788-93. PubMed ID: 14668616
    [Abstract] [Full Text] [Related]

  • 36. No association of the plasminogen activator inhibitor-1 promoter 4G/5G polymorphism with inhibitor level during basal transcription in vitro.
    Zhan M, Zhou Y, Han ZC.
    Int J Hematol; 2004 May 01; 79(4):400-4. PubMed ID: 15218974
    [Abstract] [Full Text] [Related]

  • 37. [Plasminogen activator inhibitor-1 (PAI-1) 4G/5G and angiotensin converting enzyme (ACE) I/D gene polymorphisms and fibrinolytic activity in patients with essential hypertension and dyslipidemia].
    Jastrzebska M, Widecka K, Ciechanowicz A, Goracy I, Wesołowska T, Torbus-Lisiecka B, Foltyńska-Nowakowska A, Naruszewicz M.
    Pol Arch Med Wewn; 2005 Jan 01; 113(1):7-20. PubMed ID: 16130596
    [Abstract] [Full Text] [Related]

  • 38. 4G/5G plasminogen activator inhibitor-1 polymorphisms and haplotypes are associated with pneumonia.
    Yende S, Angus DC, Ding J, Newman AB, Kellum JA, Li R, Ferrell RE, Zmuda J, Kritchevsky SB, Harris TB, Garcia M, Yaffe K, Wunderink RG, Health ABC Study.
    Am J Respir Crit Care Med; 2007 Dec 01; 176(11):1129-37. PubMed ID: 17761618
    [Abstract] [Full Text] [Related]

  • 39. [Relationship between plasminogen activator inhibitor-1 gene 4G/5G polymorphism and type 2 diabetic nephropathy in Chinese Han patients in Guangdong Province].
    Liu SQ, Xue YM, Yang GC, He FY, Zhao XS.
    Di Yi Jun Yi Da Xue Xue Bao; 2004 Aug 01; 24(8):904-7. PubMed ID: 15321757
    [Abstract] [Full Text] [Related]

  • 40. The 4G/4G genotype of the 4G/5G polymorphism of the type-1 plasminogen activator inhibitor (PAI-1) gene is a determinant of penetrating behaviour in patients with Crohn's disease.
    Sans M, Tàssies D, Pellisé M, Espinosa G, Quintó L, Piqué JM, Reverter JC, Panés J.
    Aliment Pharmacol Ther; 2003 Apr 01; 17(8):1039-47. PubMed ID: 12694086
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.